Evidence map›Paper›PMID 35002264›Full record

ArticleClinicoEconomics and outcomes research : CEOR2021

Direct and Indirect Costs of Asthma Burden in Abu Dhabi: A Retrospective Analysis of Insurance Claims Data from 2015 to 2018.

Khulood Al Mazrouei, Asma Ibrahim Almannaei, Faiza Medeni Nur, Nagham Bachnak, Ashraf Alzaabi

Open access · goldAbstract read
In one paragraph

Article in ClinicoEconomics and outcomes research : CEOR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Over-prescription of short-acting βAsthma research and practice · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Khulood Al MazroueiPulmonology Department, Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Asma Ibrahim AlmannaeiDepartment of Health, Healthcare Quality Division at the Abu Dhabi Health Authority, Abu Dhabi, United Arab Emirates.
Faiza Medeni NurHealthcare Data and Analytics Division, Department of Health, Abu Dhabi Health Authority, Abu Dhabi, United Arab Emirates.
Nagham BachnakHealthcare Data and Analytics Division, Department of Health, Abu Dhabi Health Authority, Abu Dhabi, United Arab Emirates.
Ashraf AlzaabiRespiratory Medicine Division, Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Abu Dhabi Health Services · AEZayed Military Hospital · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAsthma causes a high economic burden on the health-care system. Previous research on the cost of asthma in Abu Dhabi was in 2011 and revealed high medical costs. This work aimed to estimate both direct and indirect costs of asthma with trend analysis over a period of four years. PATIENTS AND

methodsAll data on medical costs, work absenteeism, and mortality were collected from the e-claims system of the national health insurance database. Medical costs included medication use, emergency room (ER) visits, non-ER visits, outpatient care, and hospitalization from 2015 to 2018. Indirect costs in terms of work absenteeism were calculated by multiplying the average daily income per employer by the number of workdays missed due to sick leaves documented in the database in 2019.

resultsOver the years, the total medical costs increased from AED 161,843,698 in 2015 to AED 206,548,620 in 2018. The largest contribution was attributed to outpatient care, while hospitalization accounted for the smallest proportion of the total costs in 2018. Likewise, the mean annual per-patient cost in 2015 was AED 1119 and increased to AED 1162 in 2018. Indirect costs were estimated to be AED 27,482,319 resulting from 30,948 sick leaves in the year 2019 only.

conclusionAsthma is a cause for huge expenditure from the health-care system perspective in Abu Dhabi. It also has a large impact on society through work absenteeism. Costs of asthma management are increasing every year, which suggests a call-to-action to improve the disease management status using cost-effective strategies.

Indexed as

Abu Dhabiasthmadirect costeconomic burdenindirect cost

Identifiers

PMID35002264
PMCPMC8721945
OpenAlexW4200118207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.